Skip to content

Redmile Group, LLC

Follow

13F filer, CIK 1425738, LARKSPUR, CA

Redmile Group, LLC reported $1,366,251,642 across 44 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 71.63% of the portfolio.

Accepted , ingested 13F-HR 0000905148-26-004923

Period
2026-09-30
Reported value
$1.37B
Holdings
44
Top 10 weight
71.63%
New
6
Sold out
1

Part of the filer group Redmile Group, LLC

  • Jeremy C. Green
  • Redmile Biopharma Investments III, L.P.
  • Redmile Biopharma Investments II, L.P.
  • Redmile Capital Offshore II Master Fund, Ltd.
How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
NRIXadded+3,827,298$90.7M
ETRAnew+5,430,918$61.1M
ATTOnew+1,163,587$19.9M
ADRXnew+769,345$15.3M
OBXnew+833,157$11.4M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
SRRKreduced-1,277,130-$61.7M
KRYSreduced-104,321-$34.7M
STTKreduced-1,805,043-$12.3M
IMNMreduced-548,526-$11.8M
AGMBreduced-993,696-$11M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0000905148-26-004923, largest first. % of portfolio is the value over $1,366,251,642, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,192,627 shares; 2025Q1: 4,051,927 shares; 2025Q2: 3,732,888 shares; 2025Q3: 3,678,394 shares; 2025Q4: 8,093,908 shares; 2026Q1: 7,732,808 shares; 2026Q2: 4,073,787 shares; 2026Q3: 7,901,085 shares 7,901,085$187M13.71%+3,827,298Timeline
KRYSKRYSTAL BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 753,175 shares; 2025Q1: 737,675 shares; 2025Q2: 663,471 shares; 2025Q3: 661,388 shares; 2025Q4: 677,705 shares; 2026Q1: 673,505 shares; 2026Q2: 632,005 shares; 2026Q3: 527,684 shares 527,684$175M12.84%-104,321Timeline
SRRKSCHOLAR ROCK HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,549,881 shares; 2025Q1: 4,398,281 shares; 2025Q2: 3,929,039 shares; 2025Q3: 3,904,456 shares; 2025Q4: 5,220,846 shares; 2026Q1: 9,066,621 shares; 2026Q2: 4,311,092 shares; 2026Q3: 3,033,962 shares 3,033,962$147M10.73%-1,277,130Timeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,593,629 shares; 2025Q1: 4,485,981 shares; 2025Q2: 4,375,931 shares; 2025Q3: 4,175,542 shares; 2025Q4: 4,034,070 shares; 2026Q1: 4,164,120 shares; 2026Q2: 3,945,920 shares; 2026Q3: 3,869,028 shares 3,869,028$101M7.36%-76,892Timeline
IMNMIMMUNOME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,828,026 shares; 2025Q1: 5,361,187 shares; 2025Q2: 4,872,225 shares; 2025Q3: 5,023,385 shares; 2025Q4: 5,718,385 shares; 2026Q1: 5,558,885 shares; 2026Q2: 4,911,590 shares; 2026Q3: 4,363,064 shares 4,363,064$93.8M6.87%-548,526Timeline
ABSIABSCI CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,253,316 shares; 2025Q1: 8,253,316 shares; 2025Q2: 8,253,316 shares; 2025Q3: 8,253,316 shares; 2025Q4: 8,253,316 shares; 2026Q1: 8,253,316 shares; 2026Q2: 6,739,675 shares; 2026Q3: 6,671,377 shares 6,671,377$71.9M5.26%-68,298Timeline
ETRAELECTRA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 5,430,918 shares 5,430,918$61.1M4.47%newTimeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,300,644 shares; 2025Q1: 6,300,644 shares; 2025Q2: 6,300,644 shares; 2025Q3: 6,300,644 shares; 2025Q4: 10,050,644 shares; 2026Q1: 14,549,768 shares; 2026Q2: 11,869,877 shares; 2026Q3: 14,278,075 shares 14,278,075$60.4M4.42%+2,408,198Timeline
NGNENEUROGENE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,319,763 shares; 2025Q1: 1,308,063 shares; 2025Q2: 1,276,676 shares; 2025Q3: 1,299,022 shares; 2025Q4: 1,459,599 shares; 2026Q1: 1,459,599 shares; 2026Q2: 1,412,199 shares; 2026Q3: 1,562,199 shares 1,562,199$43.5M3.18%+150,000Timeline
RGNXREGENXBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,794,780 shares; 2025Q1: 4,794,780 shares; 2025Q2: 4,775,717 shares; 2025Q3: 4,693,389 shares; 2025Q4: 4,368,804 shares; 2026Q1: 4,368,804 shares; 2026Q2: 4,368,804 shares; 2026Q3: 5,048,502 shares 5,048,502$38M2.78%+679,698Timeline
STTKSHATTUCK LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,539,724 shares; 2025Q1: 5,539,724 shares; 2025Q2: 5,539,724 shares; 2025Q3: 5,539,724 shares; 2025Q4: 5,539,724 shares; 2026Q1: 5,539,724 shares; 2026Q2: 6,892,033 shares; 2026Q3: 5,086,990 shares 5,086,990$34.7M2.54%-1,805,043Timeline
FATEFATE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 12,872,946 shares; 2025Q1: 12,872,946 shares; 2025Q2: 12,872,946 shares; 2025Q3: 12,872,946 shares; 2025Q4: 12,872,946 shares; 2026Q1: 12,872,946 shares; 2026Q2: 12,872,946 shares; 2026Q3: 12,872,946 shares 12,872,946$30.5M2.23%02026-11-05, 13D/A: 19,164,572 shares, 14.99% of the class, 13D/A filed 2026-11-09 Timeline
SLNSILENCE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,399,317 shares; 2025Q1: 2,214,947 shares; 2025Q2: 2,164,777 shares; 2025Q3: 2,164,777 shares; 2025Q4: 2,164,777 shares; 2026Q1: 2,164,777 shares; 2026Q2: 2,164,777 shares; 2026Q3: 2,460,894 shares 2,460,894$26.9M1.97%+296,117Timeline
BEAMBEAM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,528,567 shares; 2025Q1: 1,610,329 shares; 2025Q2: 1,423,411 shares; 2025Q3: 1,387,559 shares; 2025Q4: 1,285,859 shares; 2026Q1: 1,237,659 shares; 2026Q2: 1,164,259 shares; 2026Q3: 1,061,782 shares 1,061,782$26M1.9%-102,477Timeline
ATTOATTOVIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,163,587 shares 1,163,587$19.9M1.46%newTimeline
AGMBAGOMAB THERAPEUTICS NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 156,250 shares; 2026Q2: 2,733,926 shares; 2026Q3: 1,740,230 shares 1,740,230$19.3M1.41%-993,696Timeline
NUVBNUVATION BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,031,009 shares; 2025Q1: 3,031,009 shares; 2025Q2: 3,031,009 shares; 2025Q3: 3,031,009 shares; 2025Q4: 3,163,256 shares; 2026Q1: 3,153,256 shares; 2026Q2: 3,031,009 shares; 2026Q3: 3,031,009 shares 3,031,009$17M1.24%0Timeline
ADRXADARX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 769,345 shares 769,345$15.3M1.12%newTimeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 619,300 shares; 2025Q1: 534,600 shares; 2025Q2: 432,494 shares; 2025Q3: 742,017 shares; 2025Q4: 742,017 shares; 2026Q1: 521,117 shares; 2026Q2: 640,202 shares; 2026Q3: 381,319 shares 381,319$14.7M1.07%-258,883Timeline
ADCTADC THERAPEUTICS SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 15,666,731 shares; 2025Q1: 15,666,731 shares; 2025Q2: 15,666,731 shares; 2025Q3: 15,666,731 shares; 2025Q4: 15,666,731 shares; 2026Q1: 15,470,502 shares; 2026Q2: 11,526,710 shares; 2026Q3: 11,584,552 shares 11,584,552$14.1M1.03%+57,842Timeline
SLDBSOLID BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 615,246 shares; 2025Q1: 2,019,171 shares; 2025Q2: 1,915,926 shares; 2025Q3: 1,899,342 shares; 2025Q4: 1,860,542 shares; 2026Q1: 2,011,895 shares; 2026Q2: 1,948,695 shares; 2026Q3: 1,944,342 shares 1,944,342$14.1M1.03%-4,353Timeline
ZYMEZYMEWORKS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,840,463 shares; 2025Q1: 4,788,945 shares; 2025Q2: 4,150,627 shares; 2025Q3: 3,705,750 shares; 2025Q4: 491,654 shares; 2026Q1: 491,654 shares; 2026Q2: 491,654 shares; 2026Q3: 491,654 shares 491,654$13M0.95%0Timeline
OBXOBSIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 833,157 shares 833,157$11.4M0.84%newTimeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 173,859 shares; 2026Q2: 265,169 shares; 2026Q3: 189,538 shares 189,538$11.4M0.83%-75,631Timeline
CLYMCLIMB BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,226,330 shares; 2026Q3: 974,489 shares 974,489$11.2M0.82%-251,841Timeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 615,775 shares; 2025Q1: 590,175 shares; 2025Q2: 343,026 shares; 2025Q3: 327,008 shares; 2025Q4: 283,308 shares; 2026Q1: 261,508 shares; 2026Q2: 433,921 shares; 2026Q3: 321,770 shares 321,770$10.4M0.76%-112,151Timeline
ALXOALX ONCOLOGY HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,689,611 shares; 2025Q1: 3,640,834 shares; 2025Q2: 3,391,455 shares; 2025Q3: 3,332,983 shares; 2025Q4: 3,264,718 shares; 2026Q1: 7,964,188 shares; 2026Q2: 7,392,504 shares; 2026Q3: 7,185,263 shares 7,185,263$9.99M0.73%-207,241Timeline
AURAAURA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,666,667 shares; 2026Q3: 1,552,479 shares 1,552,479$9.75M0.71%-114,188Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,554,836 shares; 2025Q1: 3,216,026 shares; 2025Q2: 1,448,040 shares; 2025Q3: 2,209,118 shares; 2025Q4: 1,437,918 shares; 2026Q1: 688,036 shares; 2026Q2: 503,321 shares; 2026Q3: 296,606 shares 296,606$9.5M0.7%-206,715Timeline
CBLLCERIBELL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 435,239 shares; 2025Q1: 435,239 shares; 2025Q2: 435,239 shares; 2025Q3: 435,239 shares; 2025Q4: 435,239 shares; 2026Q1: 386,786 shares; 2026Q2: 386,786 shares; 2026Q3: 386,786 shares 386,786$9.43M0.69%0Timeline
ODTXODYSSEY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 425,000 shares; 2026Q3: 374,510 shares 374,510$8.32M0.61%-50,490Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 133,882 shares; 2026Q1: 262,674 shares; 2026Q2: 229,374 shares; 2026Q3: 191,036 shares 191,036$7.1M0.52%-38,338Timeline
LIVNLIVANOVA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,043,539 shares; 2025Q1: 1,014,139 shares; 2025Q2: 934,271 shares; 2025Q3: 926,799 shares; 2025Q4: 118,054 shares; 2026Q1: 108,354 shares; 2026Q2: 93,154 shares; 2026Q3: 84,132 shares 84,132$6.44M0.47%-9,022Timeline
ATRAATARA BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 441,701 shares; 2025Q1: 441,701 shares; 2025Q2: 441,701 shares; 2025Q3: 441,701 shares; 2025Q4: 441,701 shares; 2026Q1: 441,701 shares; 2026Q2: 441,701 shares; 2026Q3: 636,852 shares 636,852$5.41M0.4%+195,151Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 51,234 shares; 2026Q3: 42,902 shares 42,902$4.9M0.36%-8,332Timeline
EPRXEUPRAXIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 700,000 shares; 2026Q2: 611,400 shares; 2026Q3: 519,881 shares 519,881$4.73M0.35%-91,519Timeline
DBVTDBV TECHNOLOGIES S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 549,840 shares; 2026Q1: 491,340 shares; 2026Q2: 410,440 shares; 2026Q3: 373,417 shares 373,417$4.39M0.32%-37,023Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 448,110 shares; 2026Q1: 415,710 shares; 2026Q2: 362,010 shares; 2026Q3: 292,817 shares 292,817$3.94M0.29%-69,193Timeline
TCGXTCGX ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 299,860 shares 299,860$3.75M0.27%newTimeline
PRMEPRIME MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,074,350 shares; 2025Q1: 2,074,350 shares; 2025Q2: 2,074,350 shares; 2025Q3: 87,118 shares; 2025Q4: not reported; 2026Q1: 1,590,832 shares; 2026Q2: 1,389,632 shares; 2026Q3: 1,146,860 shares 1,146,860$3.5M0.26%-242,772Timeline
IVVDINVIVYD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,012,254 shares; 2025Q1: 2,285,320 shares; 2025Q2: 2,285,320 shares; 2025Q3: 2,285,320 shares; 2025Q4: 2,681,159 shares; 2026Q1: 2,648,659 shares; 2026Q2: 2,597,759 shares; 2026Q3: 2,285,320 shares 2,285,320$1.99M0.15%-312,439Timeline
OCULOCULAR THERAPEUTIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 243,954 shares 243,954$1.87M0.14%newTimeline
ARDXARDELYX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,576,259 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 733,350 shares; 2026Q2: 641,750 shares; 2026Q3: 523,870 shares 523,870$1.79M0.13%-117,880Timeline
PLRXPLIANT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,895,478 shares; 2025Q1: 2,053,559 shares; 2025Q2: 1,632,577 shares; 2025Q3: 1,591,695 shares; 2025Q4: 1,616,228 shares; 2026Q1: 772,126 shares; 2026Q2: 772,126 shares; 2026Q3: 772,126 shares 772,126$834K0.06%0Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ESTAESTABLISHMENT LABS HLDGS INC88,964$7.63Mshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000905148-26-004923 base2026-11-16